1. AB0253 Rapid remission during the first year in early active rheumatoid arthritis is associated with better 5 years structural damage outcomes. (12th June 2018) Authors: Legrand, J.; Kirchgesner, T.; Sokolova, T.; Vande Berg, B.; Durez, P. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1308 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0281 Remission rates during golimumab treatment for rheumatoid arthritis are associated with differences in baseline disease states across geographic regions in the go-more study. (23rd January 2014) Authors: Durez, P.; Pavelka, K.; Lazaro, M.; Garcia Kutzbach, A.; Moots, R.; Amital, H.; Yao, R.; Govoni, M.; Vastesaeger, N.; Weng, H. H. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A872 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0291 Identification of joint locations that are poor prognostic indicators and require more intensive therapy in an early, rapidly progressing ra cohort: a post hoc agree analysis. (12th June 2018) Authors: Durez, P.; Robert, S.; Thiry, A.; Ahmad, H.A. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0323 Weekly subcutaneous abatacept confers comparable onset of treatment response and magnitude of efficacy improvement over 6 months when administered with or without an intravenous abatacept loading dose. (23rd January 2014) Authors: Schiff, M.; Alten, R.; Weinblatt, M.; Nash, P.; Fleischmann, R.; Durez, P.; Kaine, J.; Delaet, I.; Kelly, S.; Maldonado, M.; Patel, S.; Genovese, M. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A886 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0405 Baseline Predictors of Remission Rates during Golimumab Treatment for Rheumatoid Arthritis in the GO-MORE Study. (10th June 2014) Authors: Durez, P.; Pavelka, K.; Lazaro, M.; Garcia Kutzbach, A.; Moots, R.; Amital, H.; Yao, R.; Huyck, S.; Govoni, M.; Weng, H.H.; Vastesaeger, N. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 941 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0506 Enhanced improvement in fatigue from RA treatment with secukinumab: An application of IRT methodology. (23rd January 2014) Authors: Gnanasakthy, A.; Kosinski, M.; Durez, P.; Mallya, U.; Mpofu, S. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. AB1121 The Forgotten Joint Score, A New Questionnaire to Evaluate Patient's Perception of Total Knee and Hip Arthroplasty in Patients with Established Rheumatoid Arthritis. (10th June 2014) Authors: Azzi, E.; Thienpont, E.; Avaux, M.; Houssiau, F.A.; Durez, P. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 1173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. AB1172 Does ultrasound-scored synovitis depend on the pharmacokinetics of intravenous infliximab in patients with rheumatoid arthritis?. (12th June 2018) Authors: Ishchenko, A.; Lecouvet, F.E.; Durez, P.; Stoenoiu, M.S. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1688 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. AB1262 Tapering of biological antirheumatic drugs in rheumatoid arthritispatients is achievable and cost effective in daily clinical practice: data from the brussels ucl ra cohort. (12th June 2018) Authors: Dierckx, S.; Lauwerys, B.; Sokolova, T.; Meric De Bellefon, L.; Stoenoiu, M.; Nzeusseu, A.; Houssiau, F.; Avramoska, A.; Durez, P. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1726 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. AB1352 Evaluation of mri ramris score and clinical response in patients with acpa positive undifferentiated arthritistreated with infliximab versus placebo. (12th June 2018) Authors: Kirchgesner, T.; Vande Berg, B.; Sokolova, T.; Meric de Bellefon, L.; Nzeusseu, A.; Stoenoiu, M.; Durez, P. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1764 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗